Table V.
Outcomes and discharge medical therapy
| Characteristic | Overall (n = 336) n (%), median (Q1–Q3) |
OCT (n = 150) n (%), median (Q1–Q3) |
IVUS (n = 186) n (%), median (Q1–Q3) |
P-value |
|---|---|---|---|---|
| Death | 22 (6.5) | 9 (6.0) | 13 (7.0) | 0.71 |
| In-hospital death | 4 (1.2) | 2 (1.3) | 2 (1.1) | 0.91 |
| All-cause death | 26 (7.7) | 11 (7.3) | 15 (8.1) | 0.81 |
| Cardiac death | 18 (5.4) | 9 (6.0) | 9 (4.8) | 0.63 |
| Non-cardiac death | 8 (2.4) | 2 (1.3) | 6 (3.2) | 0.31 |
| ACE inhibitors | 150 (45) | 62 (42) | 88 (47) | 0.31 |
| Diuretics | 118 (35) | 49 (33) | 69 (37) | 0.42 |
| β-blockers | 169 (50) | 72 (48) | 97 (52) | 0.51 |
| Statins | 304 (91) | 138 (93) | 166 (89) | 0.31 |
| Antibiotics | 24 (7.2) | 10 (6.7) | 14 (7.5) | 0.74 |